Cross Country Valuation
| CCRN Stock | USD 15.00 0.06 0.40% |
At this time, the firm appears to be undervalued. Cross Country Healthcare shows a prevailing Real Value of $16.61 per share. The current price of the firm is $15.0. Our model approximates the value of Cross Country Healthcare from analyzing the firm fundamentals such as Profit Margin of (0.01) %, current valuation of 412.46 M, and Return On Equity of -0.0328 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cross Country's valuation include:
Price Book 1.1701 | Enterprise Value | Enterprise Value Ebitda 103.3729 | Price Sales 0.3647 | Forward PE 31.1526 |
Undervalued
Today
Please note that Cross Country's price fluctuation is very steady at this time. Calculation of the real value of Cross Country Healthcare is based on 3 months time horizon. Increasing Cross Country's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cross Country is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cross Stock. However, Cross Country's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.0 | Real 16.61 | Target 17.46 | Hype 14.96 | Naive 15.14 |
The intrinsic value of Cross Country's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cross Country's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cross Country Healthcare helps investors to forecast how Cross stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cross Country more accurately as focusing exclusively on Cross Country's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cross Country's intrinsic value based on its ongoing forecasts of Cross Country's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cross Country's closest peers.
Cross Country Cash |
|
Cross Valuation Trend
Knowing Cross Country's actual value is paramount for traders when making sound investment determinations. Using both Cross Country's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Cross Country Total Value Analysis
Cross Country Healthcare is currently projected to have valuation of 412.46 M with market capitalization of 490.22 M, debt of 3.87 M, and cash on hands of 279 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cross Country fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
412.46 M | 490.22 M | 3.87 M | 279 K |
Cross Country Investor Information
About 99.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.17. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cross Country Healthcare recorded a loss per share of 0.44. The entity had not issued any dividends in recent years. Based on the key measurements obtained from Cross Country's financial statements, Cross Country Healthcare is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Cross Country Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Cross suggests not a very effective usage of assets in March.Cross Country Ownership Allocation
Cross Country holds a total of 32.81 Million outstanding shares. The majority of Cross Country Healthcare outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cross Country Healthcare to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cross Country. Please pay attention to any change in the institutional holdings of Cross Country Healthcare as this could imply that something significant has changed or is about to change at the company. Also note that nearly one million five hundred six thousand ninety-eight invesors are currently shorting Cross Country expressing very little confidence in its future performance.Cross Country Profitability Analysis
The company reported the previous year's revenue of 1.34 B. Net Loss for the year was (14.56 M) with profit before overhead, payroll, taxes, and interest of 274.25 M.About Cross Country Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cross Country Healthcare. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cross Country Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Cross Country's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cross Country's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cross Country. We calculate exposure to Cross Country's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cross Country's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 274.3 M | 220.1 M | |
| Pretax Profit Margin | (0.01) | (0.01) | |
| Operating Profit Margin | (0.01) | (0.01) | |
| Net Loss | (0.01) | (0.01) | |
| Gross Profit Margin | 0.20 | 0.28 |
Cross Country Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 33.4 M | |
| Quarterly Earnings Growth Y O Y | -0.785 | |
| Forward Price Earnings | 31.1526 |
Cross Country Current Valuation Indicators
Cross Country's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cross Country's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cross Country, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cross Country's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cross Country's worth.When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.79) | Earnings Share (0.44) | Revenue Per Share | Quarterly Revenue Growth (0.25) | Return On Assets |
The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.